The latest price target for Labcorp Hldgs (NYSE:LH) was reported by JP Morgan on November 7, 2025. The analyst firm set a price target for $317.00 expecting LH to rise to within 12 months (a possible 22.25% upside). 30 analyst firms have reported ratings in the last year.

The latest analyst rating for Labcorp Hldgs (NYSE:LH) was provided by JP Morgan, and Labcorp Hldgs maintained their overweight rating.

The last upgrade for Labcorp Holdings Inc happened on March 4, 2025 when Citigroup raised their price target to $300. Citigroup previously had a neutral for Labcorp Holdings Inc.

There is no last downgrade for Labcorp Hldgs.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Labcorp Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Labcorp Hldgs was filed on November 7, 2025 so you should expect the next rating to be made available sometime around November 7, 2026.

While ratings are subjective and will change, the latest Labcorp Hldgs (LH) rating was a maintained with a price target of $291.00 to $317.00. The current price Labcorp Hldgs (LH) is trading at is $259.30, which is out of the analyst’s predicted range.